Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 11,632

Document Document Title
WO/2021/070120A1
The preparation of transdermal pharmaceutical compositions comprising cannabidiol (CBD) and use thereof in the treatment of seizure disorders is disclosed. Preferably, the CBD is provided in the form of a highly purified extract of canna...  
WO/2021/065653A1
A powder for a compound represented by general formula (A). For example, the mode diameter Dm for this powder, measured using the laser diffraction scattering method, is 75–150 μm and the Ca ion content is less than 1 ppm. In general ...  
WO/2021/062561A1
There is provided a method for cultivating and harvesting cannabis plants, comprising: cultivating a batch of a plurality of cannabis plants in a grow area, processing plant material from a portion of the plurality of cannabis plants in ...  
WO/2021/054607A1
The present invention relates to a method for decomposing a phenolic by-product and, more specifically, to a method for decomposing a phenolic by-product comprising the steps of: (S10) mixing a mixed by-product stream of a bisphenol-A by...  
WO/2021/054608A1
The present invention relates to a method for decomposing phenolic by-products and, more specifically, provides a method for decomposing phenolic by-products, the method comprising the steps of: supplying a phenolic by-product stream to ...  
WO/2021/046628A1
A stable medicinal cannabidiol composition for use in oral delivery, the composition comprising synthetic cannabidiol (CBD) having a purity of at least 99.8 %, preferably at least 99.9 %, together with beta-caryophyllene (BCP) which func...  
WO/2021/047491A1
The present invention relates to a method for simultaneously separating cannabidivarin and cannabigerol, comprising: sufficiently oscillating a solvent system, allowing the solvent system to stand, and separately collecting an upper phas...  
WO/2021/046640A1
The present disclosure relates to new cannabinoid derivatives and precursors and catalytic asymmetric processes for their preparation. The disclosure also relates to pharmaceutical compositions and pharmaceutical and analytical uses of t...  
WO/2021/049294A1
Provided is a 1,1'-Bi-2-naphthol powder in which particles do not easily agglomerate during storage. A 1,1'-Bi-2-naphthol powder powder according to an embodiment of the present invention has a frequency distribution, obtained by dry par...  
WO/2021/049293A1
Provided is a method for producing a 1-1'-bi-2-naphthol compound of good color. A method for producing a 1-1'-bi-2-naphthol compound, according to an embodiment of the present invention, includes a step of obtaining a 1-1'-bi-2-naphthol ...  
WO/2021/046636A1
The present disclosure relates to new cannabinoid derivatives and precursors and processes for their preparation. The disclosure also relates to pharmaceutical and analytical uses of the new cannabinoid derivatives.  
WO/2021/042721A1
Disclosed is a method for preparing m-trifluoromethylphenol. The present invention provides a method for preparing m-trifluoromethylphenol, which comprises the following steps: step (1): in a continuous flow reactor, subjecting an aqueou...  
WO/2021/035344A1
Disclosed herein is a method for upgrading a cannabinoid mixture that comprises tetrahydrocannabinol (THC) and one or more non-THC cannabinoids, when the cannabinoid mixture has a THC content of less than about 20 wt. %. The method compr...  
WO/2021/041506A1
Naphthoquinone derivatives of Lawsone have been found to be effective against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA). Such compounds generally contain a substituent group at the 3-position of a speci...  
WO/2021/030913A1
The present disclosure relates to cannabinoid compositions that are rehydratable and that upon such rehydration retain at least some of the properties of the original cannabinoid emulsions from which the cannabinoid composition was obtai...  
WO/2021/030690A2
Disclosed herein are systems and methods of depolymerizing a lignin component of a lignin-containing material. The method comprising contacting the lignin-containing material with a solvent and optionally a catalyst at a temperature in t...  
WO/2021/029395A1
A compound which has one or more halogen atoms and an unsaturated double bond. A method for producing an iodine-containing vinyl monomer, said method comprising: (a) a step for preparing an iodine-containing alcoholic substrate having a ...  
WO/2021/022469A1
The present invention provides a continuous synthesis-purification integrated device and a continuous reaction system containing the same. The continuous synthesis-purification integrated device comprises: a reaction section, a purificat...  
WO/2021/022378A1
The current application relates to a composition comprising a cannabis extract and a lipid-based carrier; wherein the lipid-based carrier comprises omega-3 fatty acids and at least one of monoacylglycerides, diacylglycerides, triglycerid...  
WO/2021/016717A1
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a mixing vessel, a volatizing unit, and a distillation unit. The mixing vessel combines a first in...  
WO/2021/016716A1
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a first reaction vessel, a volatizing unit, and a distillation unit. The first reaction vessel pro...  
WO/2021/016987A1
A pharmaceutical compound TG1 (2, 3, 5, 4'-tetrahydroxy-trans-stilbene) and a new use for treating colorectal cancer thereofare provided. The pharmaceutical compound has the structure of formula I. Each variable in formula I and treating...  
WO/2021/016718A1
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a volatizing unit, a fractional distillation unit, and a condensing unit. The volatizing unit rece...  
WO/2021/012046A1
There are provided compositions comprising at least one compound chosenfrom compound of formula (I), compound of formula (II), compound of formula (III) and compound of formula (IV) and a cannabinoid extract.  
WO/2021/007661A1
The current application relates to cannabinoid derivatives of formula (I) and pharmaceutical compositions comprising the same. The cannabinoid derivative can be used for the treatment of diseases associated with cannabinoid receptor such...  
WO/2021/001044A1
Object of the present invention is an improved process for the preparation of key intermediates for the synthesis of Eltrombopag, passing through/using intermediate 5'-Chloro-2'-hydroxy[1,1'-biphenyl]-3-carboxylic acid alkaline metal sal...  
WO/2020/252588A1
Grafted cannabis plants and related methods for producing a grafted cannabis plant are provided. In some embodiments, a scion is provided from a first cannabis plant having at least one of a first desired phenotype and a first desired ge...  
WO/2020/257234A1
A process for isolation of bisphenol A from depolymerization of a poly(carbonate) includes depolymerizing a poly(carbonate) having repeating units derived from bisphenol A in the presence of a base, a Ci-6 alcohol, and an organic cosolve...  
WO/2020/257237A1
A process for depolymerization of poly(carbonate) includes combining a poly(carbonate) including repeating units derived from bisphenol A; bisphenol A; water; and a base under conditions effective to depolymerize the poly (carbonate). A ...  
WO/2020/248060A1
Disclosed herein is a method for converting cannabidiol (CBD) into a composition comprising Δ9-tetrahydrocannabinol (Δ9-THC) and Δ8-tetrahydrocannabinol (Δ8-THC) in which the composition has a Δ9-ΤΗC:Δ8-ΤΗC ratio of greater tha...  
WO/2020/249184A1
The present invention relates to a method for producing cannabigerol and purifying it from a reaction mixture. The present invention also relates to the cosmetic use of cannabigerol for the inhibition of tyrosinase activity and/or the re...  
WO/2020/248058A1
Disclosed herein a method for converting (cannabidiol) CBD into a composition comprising Δ8-tetrahydrocannabinol (A8-THC) and Δ9-tetrahydrocannabinol (Δ9-THC), in which the composition has a Δ8-THC:Δ9-THC ratio that is greater than ...  
WO/2020/248062A1
Disclosed herein is a method for converting a first cannabinoid into a composition comprising a second cannabinoid and a third cannabinoid, in which the second cannabinoid and the third cannabinoid are each isomers of the first cannabino...  
WO/2020/252369A1
The application relates to crystalline cannabigerol comprising at least one X-ray powder diffraction peak selected from the group consisting of 4.73°, 9.52°, 14.30°, and 23.93° 2Θ (each ± 0.20° 2Θ), to methods of making the cryst...  
WO/2020/248071A1
A method and system for isolating trichomes from plant matter. The method and system are applied to biomass including trichomes bound to structural plant material. The biomass is combined with a solution including a chelating agent for l...  
WO/2020/248059A1
Disclosed is a method for converting a first cannabinoid into a second cannabinoid that is a regioisomer of the first cannabinoid. The method comprising contacting the first cannabinoid with: (i) a base having a pKb that is less than a c...  
WO/2020/248061A1
Disclosed herein is a method for converting cannabidiol (CBD) into a composition comprising Δ9-tetrahydrocannabinol ( Δ9-THC) and Δ8-tetrahydrocannabinol ( Δ8-THC) in which the composition has a Δ9-ΤΗΟ: Δ8-ΤΗΟ ratio of greate...  
WO/2020/243844A1
The present disclosure relates to a cannabinoid composition that has enhanced absorption rates or higher concentrations of the administered cannabinoid into the systemic circulation, the composition comprising at least one cannabinoid an...  
WO/2020/237806A1
The present invention relates to the field of organic synthesis. Provided is a preparation method for 4-fluorine-3-methoxyl-5-methylaniline hydrochloride. A synthetic route of the preparation method for 4-fluorine-3-methoxyl-5-methylanil...  
WO/2020/243588A1
The present disclosure relates to the preparation of halogenated dihydroxybenzene compounds with high yield, selectivity and purity. The compounds are useful, among other things, in the synthesis of cannabinoids and cannabinoid-type comp...  
WO/2020/237388A1
A formulation for solubilizing a water insoluble pharmaceutical agent is provided. The formulation comprises: a water-insoluble pharmaceutical agent, a detergent, an enzyme that breaks down lipids, proteins, and/or starches, a plasticizi...  
WO/2020/232545A1
The present disclosure relates to new cannabinoid sulfonate esters and processes for their use to prepare cannabinoids. The disclosure also relates to the use of catalysts and catalytic processes for the preparation of cannabinoids from ...  
WO/2020/232557A1
The present technology generally relates to methods of making cocoa butter-derived products that comprise cannabinoids. The present technology further generally relates to cocoa butter-derived products resulting from such methods.  
WO/2020/232530A1
There are provided compositions comprising a purified cannabidiol (CBD) or a derivative thereof and an anti-inflammatory botanical extract, and methods of use thereof for the management of pain in a subject.  
WO/2020/234650A1
A composition comprising an active composition made up of at least 5% CBD, at least 2% β-caryophyllene, and at least 2% linalool; wherein said composition comprises a carrier and excipients to increase oral bioavailability for mammalian...  
WO/2020/214767A3
The present disclosure provides radiolabeled compounds of the formula: (I) and (II), as well as precursor compounds of the formula: (VII) wherein the variables are defined herein. The present disclosure also provides radiopharmaceutical ...  
WO/2020/233502A1
Disclosed is a method for preparing cannabidiol and analogues thereof; the method is implemented by means of reacting a resorcinol derivative with menthyl-2,8-dien-1-ol or a derivative thereof. The method of the present invention has adv...  
WO/2020/229891A1
Methods of manufacturing cannabidiol (CBD) and cannabidivarin (CBDV); intermediates of the methods of manufacturing CBD and CBDV; and crystallized CBD and CBDV obtained via described methods.  
WO/2020/227830A1
Methods for extracting one or more chemical compounds from cannabis plant material are provided. In some embodiments, the method may comprise: providing the cannabis plant material; extracting the cannabis plant material with a solvent t...  
WO/2020/223811A1
Pharmaceutical formulations are provided that include at least two antibiotically active ingredients: a cannabinoid that is one or more of cannabichromene (CBC), cannabidiol (CBD) and/or cannabigerol (CBG); a sesquiterpene that is one or...  

Matches 1 - 50 out of 11,632